DIPEPTIDE-2
DIPEPTIDE-2
DIPEPTIDE-2 (INCI: DIPEPTIDE-2) is a synthetic ingredient. It is used as a skin care agent.
Skin conditioning
Ingredient
Roles & functions
Skin conditioning — Keeps the skin in good condition and protects it; improves its comfort.
Regulatory framework
What the authorities say
| Authority | Status |
|---|---|
| Commission européenne (CosIng, Règl. 1223/2009) | Autorisé |
| CLP classification (Reg. 1272/2008) | No CMR classification |
| ECHA — endocrine disruptor (human health) | Not identified as an endocrine disruptor |
| ECHA — Candidate List (SVHC, REACH Art. 59) | Not on the Candidate List (SVHC) |
| European Commission (Reg. 1223/2009, Annex III) | No cosmetic allergen subject to mandatory labelling |
| European Commission (EU catalogue of nanomaterials, Reg. 1223/2009) | No referenced nanoform |
Products
Products containing it
NeostrataNeoStrata Repair Soin intensif des yeux
ACMACM Dépiwhite gel contour de l'œil
ACMACM Duolys Crème contour des yeux
TorridenTorriden Balanceful Sérum Équilibrant et Apaisant Centella Asiatica 50 ml
GlowGlow Peach Peptide Baume à Lèvre 8 g - Teinte : Palepink
TorridenTorriden Balanceful Crème Équilibrante et Apaisante Centella Asiatica 80 ml
FilorgaFilorga Optim Eyes Cryo
GlowGlow Peach Peptide Baume à Lèvre 8 g - Teinte : Coralreef
FilorgaFilorga Optim-Eyes contour des yeux 3 en 1
FilorgaFilorga Trousse découverte
IdcProfil Corps Crème Anti-Âge Corps Raffermissante, 200ml
IdcProfil Celluminceur Crème Anti-Âge Intensive Lipo-Expert, 150ml
Statistics
In Lou’s database
23
products listed
| Most frequent categories | Anti-aging · Eye contour · Firming & anti-stretch marks · Lips · Serums |
| Most frequent brands | Idc · Filorga · ACM · Glow · Torriden |
🔒
This information is reported factually and with attribution (authorities and publications cited). It does not constitute medical advice, for your situation, ask a pharmacist or a healthcare professional for advice.
A question about this ingredient?
Lou answers you and looks at your products with you, in store.